Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

788 Press Releases
DateTitleCompany
24 Mar 14 Merck to Present New Data for Investigational Hepatitis C Treatments MK-5172 and MK-8742 at EASL Annual Meeting/The International Liver Congress™ 2014 Merck,
Published by
Business Wire
06 Mar 14 ERBITUX® RECEIVES POSITIVE FUNDING DECISION FOR THE TREATMENT OF METASTATIC COLORECTAL CANCER IN ENGLAND Merck Serono,
Published by
PharmiWeb
06 Mar 14 Merck’s Consumer Health Division Breaks $1bn Barrier Through Transition of Neurobion and Floratil Brands from Merck Serono Merck,
Published by
Business Wire
25 Feb 14 Merck Announces Second-Quarter 2014 Dividend Merck,
Published by
Business Wire
20 Feb 14 Merck to Participate in the Citi 2014 Healthcare Conference Merck,
Published by
Business Wire
20 Feb 14 FDA Accepts for Review Merck’s Biologics License Application for V503, Investigational 9-valent Human Papillomavirus Vaccine Merck,
Published by
Business Wire
10 Feb 14 Merck and Samsung Bioepis Enter Collaboration Agreement to Develop and Commercialize Insulin Glargine Candidate for Diabetes Merck,
Published by
Business Wire
03 Feb 14 Merck Announces Canadian Approval of GRASTEK® (Standardized Allergenic Extract, Timothy Grass (Phleum pratense) Sublingual Tablet) Merck,
Published by
Business Wire
16 Jan 14 Merck Statement on FDA Advisory Committee for Vorapaxar, Merck’s Investigational Antiplatelet Medicine Merck,
Published by
Business Wire
13 Jan 14 Merck Initiates Rolling Submission of U.S. Biologics License Application for MK-3475, an Investigational Anti-PD-1 Immunotherapy, in Patients with Advanced Melanoma Merck,
Published by
Business Wire
10 Jan 14 Merck to Present at the 32nd Annual J.P. Morgan Healthcare Conference Merck,
Published by
Business Wire
06 Jan 14 Merck to Hold Fourth-Quarter 2013 Sales and Earnings Conference Call on February 5 Merck,
Published by
Business Wire
18 Dec 13 Merck Collaborates with GlaxoSmithKline to Evaluate Novel Combination Regimen for Advanced Renal Cell Carcinoma Merck,
Published by
Business Wire
13 Dec 13 Merck Statement on FDA Advisory Committee for GRASTEK® (Timothy Grass Pollen Allergen Extract), Merck’s Investigational Sublingual Allergy Immunotherapy Tablet Merck,
Published by
Business Wire
26 Nov 13 Merck Announces Increased Quarterly Dividend Merck,
Published by
Business Wire
21 Nov 13 Merck Consumer Health Turnaround on Track Merck,
Published by
Business Wire
15 Nov 13 Interim Data to Be Presented for MK-3475, Merck’s Investigational Anti-PD-1 Immunotherapy, in Patients with Advanced Melanoma Merck,
Published by
Business Wire
24 Oct 13 Merck Provides Update on Investigational 9-valent HPV Vaccine V503 to U.S. Advisory Committee on Immunization Practices Merck,
Published by
Business Wire
01 Oct 13 Merck Serono's Erbitux Significantly Extends Survival by 7.5 Months in mCRC RAS Wild-Type Patients When Compared With Bevacizumab: New Analysis of FIRE-3 AIO Study Merck Serono,
Published by
AxonComms
01 Oct 13 Merck Updates Plans for Headquarters Move in New Jersey Merck,
Published by
Business Wire
01 Oct 13 Data from Merck’s Investigational Hepatitis C Treatment Portfolio to be Presented at the 64th American Association for the Study of Liver Diseases Annual Meeting Merck,
Published by
Business Wire
01 Oct 13 Interim Data for Merck’s MK-3475, an Investigational Anti-PD-1 Immunotherapy, in Previously Treated Patients with Non-Small Cell Lung Cancer to be Presented at 15th World Conference on Lung Cancer Merck,
Published by
Business Wire
07 Oct 13 Merck Serono Makes First Awards as Part of the Company’s €1 Million Grant for Multiple Sclerosis Innovation Merck Serono
07 Oct 13 Merck Announce Cut of 8,500 Jobs Merck,
Published by
Pharmiweb.com
23 Sep 13 Merck Receives Complete Response Letter for Investigational Medicine Sugammadex Sodium Injection Merck,
Published by
Business Wire
27 Sep 13 Merck to Hold Third-Quarter 2013 Sales and Earnings Conference Call on October 28 Merck,
Published by
Business Wire
10 Sep 13 Merck Millipore Donates $30,000 to charity: water in Recognition of World Water Week Merck Millipore,
Published by
Business Wire
11 Sep 13 Merck and AstraZeneca Enter License Agreement for Investigational Oral WEE1 Kinase Inhibitor Therapy for Cancer Merck,
Published by
Business Wire
22 Oct 13 Merck Receives Breakthrough Therapy Designation for MK-5172/MK-8742, an Investigational Oral Combination Regimen for the Treatment of Chronic Hepatitis C Virus (HCV) Infection Merck,
Published by
Business Wire
23 Oct 13 ZOSTAVAX® (Zoster Vaccine Live) Awarded Prix Galien USA 2013 Best Biotechnology Product Merck,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.